CAIHL read · Jun 7, 2026

← Back to Jun 7, 2026 scan

Adversarial Co-Thinking: Calibration and Triangulation Across Multiple GenAI Tools in HCI Writing

What CAIHL does

Critical AI Health Literacy (CAIHL) is an analytical lens — Hugo Campos and Liz Salmi's 2025 National Academy of Medicine commentary, "Critical AI Health Literacy as Liberation Technology." It applies Paulo Freire's theory of critical literacy to health AI.

The central question CAIHL asks is whose interests does this AI actually serve? Four dimensions answer it: who is the primary user, where is it hosted, whose interests does it advance, and does it expand or constrain patient agency.

This deep-read separates the four dimensions on a single item from the day's scan, so you can see the specific structural shape of the AI in question — not just the bucket it landed in.

How this item reads through CAIHL

Primary user

patient

Patients, families, and care partners are the primary users of this AI.

Hosting

public

Hosted for public use (ChatGPT, Claude, consumer apps). Anyone with a device can use it.

Interests

patient-aligned

Interest structure prioritizes patients. Operates on a philanthropic, public-service, or advocacy footing.

Agency

expanding

Expands patient capabilities, supports their questions, increases their ability to act on their own values across and beyond health systems.

One-sentence synthesis

Methodological framework for multi-tool calibration; expanding agency by formalizing what literate users already do.

How this item appeared in the daily scan

Editor's note: Adversarial co-thinking is the CAIHL workflow the patient evaluator already runs informally. Naming it as a methodology is the precondition for teaching it.

Summary: arXiv preprint: A workflow framework for adversarial co-thinking across multiple GenAI tools — calibrating one against another so the user retains epistemic standing on the output.

Read the original source →

methodology

Limitations

CAIHL is a lens, not a verdict. The four dimensions are conditions of use — reassess them when a tool's business model, deployment context, or patient behavior changes. See the NAM commentary for the full framework.